Form 4: Roivant Sciences CFO Richard Pulik Reports Routine Share Disposition for Tax Obligations

Roivant Sciences Ltd.'s CFO, Richard Pulik, reported the disposition of 1,653 common shares at $11.39 per share on June 28, 2025, to cover tax withholding obligations related to vested restricted stock units.

Summary

• Richard Pulik, Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction on June 28, 2025.
• The transaction involved the disposition of 1,653 common shares.
• The shares were disposed of at a price of $11.39 per share.
• This disposition was a "net settlement" by Roivant Sciences to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following this transaction, Richard Pulik beneficially owns 399,472 common shares, which includes shares purchased under the Company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares to cover tax obligations upon RSU vesting, which is a neutral event. The significant remaining beneficial ownership is a positive, but the transaction itself is neutral.

Positives

• The remaining beneficial ownership of 399,472 common shares indicates a significant stake held by the CFO, aligning his interests with shareholders.
• The inclusion of shares purchased under the Employee Stock Purchase Plan suggests ongoing participation in company equity programs.

Future Outlook

No forward-looking statements or guidance are provided in this document.

Industry Context

This document is a routine insider transaction filing and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction, not a discretionary sale. It confirms the vesting of executive compensation.
• Employees: The mention of the Employee Stock Purchase Plan (ESPP) indicates a benefit program for employees.

Key Dates

Keywords

Roivant Sciences, ROIV, Richard Pulik, CFO, Form 4, SEC Filing, Insider Transaction, Share Disposition, Restricted Stock Units, RSU, Tax Withholding, Employee Stock Purchase Plan, ESPP, Beneficial Ownership